{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:36:30Z","timestamp":1793950590115,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jogoh.2021.102139","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T02:10:35Z","timestamp":1617847835000},"page":"102139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: A meta-analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Ying","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2021.102139_bib0001","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/humrep\/den107","article-title":"Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial","volume":"23","author":"Lainas","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0002","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0015-0282(16)59170-5","article-title":"Outcome of in vitro fertilization in women with low response to ovarian stimulation","volume":"47","author":"Pellicer","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0003","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0015-0282(16)58269-7","article-title":"High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome","volume":"65","author":"Land","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0004","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/oxfordjournals.humrep.a137459","article-title":"Comparison of 'poor' responders with 'good' responders using a standard buserelin\/human menopausal gonadotrophin regime for in-vitro fertilization","volume":"6","author":"Jenkins","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7827-9-25","article-title":"Milder is better? Advantages and disadvantages of \"mild\" ovarian stimulation for human in vitro fertilization","volume":"16","author":"Revelli","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jogoh.2021.102139_bib0006","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0015-0282(16)58269-7","article-title":"High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome","volume":"65","author":"Land","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0007","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(87)92439-1","article-title":"Prognostic assessment of female fecundity","volume":"330","author":"Navot","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jogoh.2021.102139_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1009476411762","article-title":"Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase-a function of improved embryo quality","volume":"18","author":"Schachter","year":"2001","journal-title":"Assist Reprod Genet"},{"key":"10.1016\/j.jogoh.2021.102139_bib0009","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0960-0760(93)90241-N","article-title":"Mechanistic studies on aromatase and related C-C bond elevating P-450 enzymes","volume":"44","author":"Akhtar","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jogoh.2021.102139_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7827-3-54","article-title":"The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment","volume":"3","author":"Mitwally","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jogoh.2021.102139_bib0011","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/GRF.0b013e3182353d0f","article-title":"Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome","volume":"54","author":"Casper","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2021.102139_bib0012","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jogoh.2021.102139_bib0013","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jogoh.2021.102139_bib0014","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jogoh.2021.102139_bib0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0016","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2021.102139_bib0017","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.rbmo.2011.05.012","article-title":"Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial","volume":"23","author":"Lee","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogoh.2021.102139_bib0018","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.rbmo.2009.05.007","article-title":"Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols","volume":"19","author":"Ozmen","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogoh.2021.102139_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.29252\/ijrm.15.2.101","article-title":"Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: an RCT","volume":"15","author":"Ebrahimi","year":"2017","journal-title":"Int J Reprod Biomed (Yazd)"},{"key":"10.1016\/j.jogoh.2021.102139_bib0019","first-page":"653","article-title":"Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: a double-blind randomized clinical trial","volume":"17","author":"Moini","year":"2019","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.jogoh.2021.102139_bib0021","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0022","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility","volume":"18","author":"Mitwally","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0023","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0015-0282(01)03280-0","article-title":"Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders","volume":"77","author":"Mitwally","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0024","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/09513590.2013.875997","article-title":"Effectiveness of the antagonist\/letrozole protocol for treating poor responders undergoing in vitro fertilization\/intracytoplasmic sperm injection: a systematic review and meta-analysis","volume":"30","author":"Song","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogoh.2021.102139_bib0025","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","article-title":"A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report","volume":"19","author":"Goswami","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0026","unstructured":"The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist\/aromatase inhibitor letrozole and GnRH antagonist\/clomiphene citrate protocols on IVF outcomes in poor responder patients."},{"key":"10.1016\/j.jogoh.2021.102139_bib0027","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jcem.83.7.4917","article-title":"Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations","volume":"83","author":"Weil","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jogoh.2021.102139_bib0028","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.fertnstert.2007.05.003","article-title":"Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Mullerian hormone and inhibin-B","volume":"89","author":"Andersen","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0029","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/humrep\/17.7.1724","article-title":"The concentration of inhibin B in follicular fluid: relation to oocyte maturation and embryo development","volume":"17","author":"Chang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0030","first-page":"604","article-title":"Correlations between antimullerian hormone, inhibin B, and activin A in follicular fluid in IVF\/ICSI patients for assessing the maturation and developmental potential of oocytes","volume":"12","author":"Cupisti","year":"2007","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jogoh.2021.102139_bib0031","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0032","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/humrep\/deg115","article-title":"Ultrasound examination of polycystic ovaries: is it worth counting the follicles?","volume":"18","author":"Jonard","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0033","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/humrep\/14.9.2328","article-title":"Androgens promote the IGF-I and IGF-I receptor gene expression in the primate ovary","volume":"14","author":"Vendola","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0034","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1095\/biolreprod.103.023317","article-title":"Effect of insulin-like growth factor-I during preantral follicular culture on steroidogenesis, in vitro oocyte maturation, and embryo development in mice","volume":"70","author":"Demeestere","year":"2004","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intraovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogoh.2021.102139_bib0036","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2012.03.010","article-title":"Repeated implantation failure: clinical approach","volume":"97","author":"Simon","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0037","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.fertnstert.2005.07.1283","article-title":"A randomized trial of superovulation with two different doses of letrozole","volume":"85","author":"Al-Fadhli","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2021.102139_bib0038","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility","volume":"18","author":"Mitwally","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2021.102139_bib0039","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2004.08.013","article-title":"Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation","volume":"192","author":"Mitwally","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2021.102139_bib0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1472-6483(10)61046-2","article-title":"Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility","volume":"14","author":"Badawy","year":"2007","journal-title":"Reprod Biomed"},{"key":"10.1016\/j.jogoh.2021.102139_bib0041","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00404-016-4164-0","article-title":"A comparison among different methods of letrozole combined with gonadotropin in an antagonist protocol and high-dose gonadotropin ovarian stimulation antagonist protocol in poor ovarian responders undergoing in vitro fertilization","volume":"294","author":"Yang","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogoh.2021.102139_bib0042","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.0001-6349.2004.00480.x","article-title":"GnRH antagonists in poor responders","volume":"83","author":"Kolibianakis","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogoh.2021.102139_bib0043","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.fertnstert.2013.08.024","article-title":"The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis","volume":"100","author":"Xiao","year":"2013","journal-title":"Fertil Steril"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784721000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784721000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:09:25Z","timestamp":1762628965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784721000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2468784721000775"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102139","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102139"}}